129 related articles for article (PubMed ID: 17597108)
1. IGF-1 and IGFBP-3: Risk of prostate cancer among men in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
Weiss JM; Huang WY; Rinaldi S; Fears TR; Chatterjee N; Chia D; Crawford ED; Kaaks R; Hayes RB
Int J Cancer; 2007 Nov; 121(10):2267-73. PubMed ID: 17597108
[TBL] [Abstract][Full Text] [Related]
2. Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.
Douglas JB; Silverman DT; Pollak MN; Tao Y; Soliman AS; Stolzenberg-Solomon RZ
Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2298-306. PubMed ID: 20699371
[TBL] [Abstract][Full Text] [Related]
3. Circulating insulin-like growth factor-I and binding protein-3 and risk of prostate cancer.
Severi G; Morris HA; MacInnis RJ; English DR; Tilley WD; Hopper JL; Boyle P; Giles GG
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1137-41. PubMed ID: 16775172
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factors and prostate cancer: a population-based case-control study in China.
Chokkalingam AP; Pollak M; Fillmore CM; Gao YT; Stanczyk FZ; Deng J; Sesterhenn IA; Mostofi FK; Fears TR; Madigan MP; Ziegler RG; Fraumeni JF; Hsing AW
Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):421-7. PubMed ID: 11352850
[TBL] [Abstract][Full Text] [Related]
5. Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men.
Woodson K; Tangrea JA; Pollak M; Copeland TD; Taylor PR; Virtamo J; Albanes D
Cancer Res; 2003 Jul; 63(14):3991-4. PubMed ID: 12873996
[TBL] [Abstract][Full Text] [Related]
6. Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort.
Spitz MR; Barnett MJ; Goodman GE; Thornquist MD; Wu X; Pollak M
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1413-8. PubMed ID: 12433720
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps.
Schoen RE; Weissfeld JL; Kuller LH; Thaete FL; Evans RW; Hayes RB; Rosen CJ
Gastroenterology; 2005 Aug; 129(2):464-75. PubMed ID: 16083703
[TBL] [Abstract][Full Text] [Related]
8. Relation of serum insulin-like growth factor-I (IGF-I) and IGF binding protein-3 to risk of prostate cancer (United States).
Li L; Yu H; Schumacher F; Casey G; Witte JS
Cancer Causes Control; 2003 Oct; 14(8):721-6. PubMed ID: 14674736
[TBL] [Abstract][Full Text] [Related]
9. Plasma insulin-like growth factor-1 and binding protein-3 and subsequent risk of prostate cancer in the PSA era.
Platz EA; Pollak MN; Leitzmann MF; Stampfer MJ; Willett WC; Giovannucci E
Cancer Causes Control; 2005 Apr; 16(3):255-62. PubMed ID: 15947877
[TBL] [Abstract][Full Text] [Related]
10. Circulating free insulin-like growth factor (IGF)-I, total IGF-I, and IGF binding protein-3 levels do not predict the future risk to develop prostate cancer: results of a case-control study involving 201 patients within a population-based screening with a 4-year interval.
Janssen JA; Wildhagen MF; Ito K; Blijenberg BG; Van Schaik RH; Roobol MJ; Pols HA; Lamberts SW; Schröder FH
J Clin Endocrinol Metab; 2004 Sep; 89(9):4391-6. PubMed ID: 15356036
[TBL] [Abstract][Full Text] [Related]
11. High levels of circulating insulin-like growth factor-I increase prostate cancer risk: a prospective study in a population-based nonscreened cohort.
Stattin P; Rinaldi S; Biessy C; Stenman UH; Hallmans G; Kaaks R
J Clin Oncol; 2004 Aug; 22(15):3104-12. PubMed ID: 15284261
[TBL] [Abstract][Full Text] [Related]
12. Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein 3, and insulin.
Chen C; Lewis SK; Voigt L; Fitzpatrick A; Plymate SR; Weiss NS
Cancer; 2005 Jan; 103(1):76-84. PubMed ID: 15540247
[TBL] [Abstract][Full Text] [Related]
13. Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts.
Wolpin BM; Michaud DS; Giovannucci EL; Schernhammer ES; Stampfer MJ; Manson JE; Cochrane BB; Rohan TE; Ma J; Pollak MN; Fuchs CS
Br J Cancer; 2007 Jul; 97(1):98-104. PubMed ID: 17533398
[TBL] [Abstract][Full Text] [Related]
14. Circulating insulin-like growth factor (IGF)-I and IGF binding protein (IGFBP)-3 levels and postmenopausal breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial (PLCO) cohort.
Schairer C; McCarty CA; Isaacs C; Sue LY; Pollak MN; Berg CD; Ziegler RG
Horm Cancer; 2010 Apr; 1(2):100-11. PubMed ID: 21761353
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer risk in relation to selected genetic polymorphisms in insulin-like growth factor-I, insulin-like growth factor binding protein-3, and insulin-like growth factor-I receptor.
Chen C; Freeman R; Voigt LF; Fitzpatrick A; Plymate SR; Weiss NS
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2461-6. PubMed ID: 17164371
[TBL] [Abstract][Full Text] [Related]
16. Serum insulin-like growth factor-I, insulin-like growth factor binding protein-3, and the risk of pancreatic cancer death.
Lin Y; Tamakoshi A; Kikuchi S; Yagyu K; Obata Y; Ishibashi T; Kawamura T; Inaba Y; Kurosawa M; Motohashi Y; Ohno Y
Int J Cancer; 2004 Jul; 110(4):584-8. PubMed ID: 15122592
[TBL] [Abstract][Full Text] [Related]
17. [Association of insulin, insulin-like growth factor and insulin-like growth factor binding proteins with the risk of colorectal cancer].
Jiang B; Liu DB; Zhang X; DU LL; Han CZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 May; 12(3):264-8. PubMed ID: 19434535
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor-I and binding protein-3 and risk of cancer.
Giovannucci E
Horm Res; 1999; 51 Suppl 3():34-41. PubMed ID: 10592442
[TBL] [Abstract][Full Text] [Related]
19. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.
Ma J; Pollak MN; Giovannucci E; Chan JM; Tao Y; Hennekens CH; Stampfer MJ
J Natl Cancer Inst; 1999 Apr; 91(7):620-5. PubMed ID: 10203281
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D receptor gene polymorphisms, insulin-like growth factors, and prostate cancer risk: a population-based case-control study in China.
Chokkalingam AP; McGlynn KA; Gao YT; Pollak M; Deng J; Sesterhenn IA; Mostofi FK; Fraumeni JF; Hsing AW
Cancer Res; 2001 Jun; 61(11):4333-6. PubMed ID: 11389055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]